APA (7th ed.) Citation

Hisham A. Badreldin, Nada Alsuhebany, Mohammed Alzahrani, Abdulmajeed M. Alshehri, Maha Aldoughaim, Saleh Alqifari, . . . Tariq Alqahtani. (2024). Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition. Elsevier.

Chicago Style (17th ed.) Citation

Hisham A. Badreldin, Nada Alsuhebany, Mohammed Alzahrani, Abdulmajeed M. Alshehri, Maha Aldoughaim, Saleh Alqifari, Omar Yassin, Lama Alfehaid, and Tariq Alqahtani. Abelacimab: A Leap Forward in Anticoagulation with FXI and FXIa Inhibition. Elsevier, 2024.

MLA (9th ed.) Citation

Hisham A. Badreldin, et al. Abelacimab: A Leap Forward in Anticoagulation with FXI and FXIa Inhibition. Elsevier, 2024.